Senate Bill S959 is scheduled for a vote in the Senate as early as September. This bill, “The Pharmaceutical Quality Security and Accountability Act”, has implications that could negatively affect the access of doctors and patients to compounded prescriptions. If you are a doctor or patient who uses compounded medications, please act now to educate yourself on this bill and to contact your state’s congressional representatives.
Although S959 was originally intended to prevent another tragedy like the 2012 meningitis outbreak linked to products compounded by the New England Compounding Center, the bill’s current form creates broad intrusions into the practice of medicine and the relationship between doctor, pharmacist and patient, while negatively impacting patient care. NECC was in violation of current laws, and had been cited previously for violations by FDA.









0 Comments